BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 1212252)

  • 1. Studies on the selective inhibition of membrane-bound rat liver monoamine oxidase.
    Mantle TJ; Wilson K; Long RF
    Biochem Pharmacol; 1975 Nov; 24(22):2031-8. PubMed ID: 1212252
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetic studies of membrane-bound rat liver monoamine oxidase.
    Mantle TJ; Wilson K; Long RF
    Biochem Pharmacol; 1975 Nov; 24(22):2039-46. PubMed ID: 1212253
    [No Abstract]   [Full Text] [Related]  

  • 3. Substrate-selective inhibition of monoamine oxidase by some cyclopropylamino substituted oxadiazoles.
    Long RF; Mantle TJ; Wilson K
    Biochem Pharmacol; 1976 Feb; 25(3):247-52. PubMed ID: 1267821
    [No Abstract]   [Full Text] [Related]  

  • 4. [Conjugated dinitrocompound dianions as inhibitors of the oxidative deamination of monoamines].
    Gureeva ZP; Mostiaeva LV
    Biokhimiia; 1984 Nov; 49(11):1840-6. PubMed ID: 6549266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of some monoamine oxidase inhibitors on deamination of biogenic monoamines by rat liver mitochondrial monoamine oxidase.
    Gorkin VZ; Gridneva LI; Klyashtorin LB; Veryovkina IV; Vina I
    Experientia; 1966 Mar; 22(3):157. PubMed ID: 5960880
    [No Abstract]   [Full Text] [Related]  

  • 6. Benzo-2,1,5-oxadiazoles--a novel class of heterocyclic monoamine oxidase inhibitors.
    Bolt AG; Ghosh PB
    Biochem Pharmacol; 1974 Jul; 23(14):1963-8. PubMed ID: 4422659
    [No Abstract]   [Full Text] [Related]  

  • 7. Deamination of 5-methoxytryptamine, serotonin and phenylethylamine by rat MAO in vitro and in vivo.
    Prozialek WC; Vogel WH
    Life Sci; 1978 Feb; 22(7):561-9. PubMed ID: 272480
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
    Fuller RW
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):32-7. PubMed ID: 4386711
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of 3,4-dimethoxyphenethylamine derivatives on monoamine oxidase.
    Keller WJ; Ferguson GG
    J Pharm Sci; 1977 Jul; 66(7):1048-50. PubMed ID: 886445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the substrate-binding sites of the active centre of mitochondrial monoamine oxidase.
    Severina IS
    Eur J Biochem; 1973 Oct; 38(2):239-46. PubMed ID: 4773873
    [No Abstract]   [Full Text] [Related]  

  • 11. Deamination of beta-phenylethylamine by monoamine oxidase--inhibition by imipramine.
    Roth JA; Gillis CN
    Biochem Pharmacol; 1974 Sep; 23(18):2537-45. PubMed ID: 4412708
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple binding sites of human brain and liver monoamine oxidase: substrate specificities, selective inhibitions, and attempts to separate enzyme forms.
    White HL; Glassman AT
    J Neurochem; 1977 Dec; 29(6):987-97. PubMed ID: 599351
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
    Gol'dina OA; Zagorevskiĭ VA; Lopatina KI; Sokolova TV; Gankina EM
    Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monoamine oxidase. 12. Substrate specificity of monoamine oxidase in the rabbit brain and liver].
    Nabatame E
    Nihon Yakurigaku Zasshi; 1971 Jul; 67(4):374-86. PubMed ID: 5165262
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of different substrates on the inhibition of rat brain and liver monoamine oxidase by arylalkylhydrazines.
    Popov N; Matthies H; Lietz W; Thiemann C; Jassmann E
    Biochem Pharmacol; 1970 Aug; 19(8):2413-8. PubMed ID: 5520601
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of monoamine oxidase by amphetamine and related compounds.
    Mantle TJ; Tipton KF; Garrett NJ
    Biochem Pharmacol; 1976 Sep; 25(18):2073-7. PubMed ID: 985546
    [No Abstract]   [Full Text] [Related]  

  • 17. Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain.
    Garrick NA; Murphy DL
    Psychopharmacology (Berl); 1980; 72(1):27-33. PubMed ID: 6781004
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective inhibition of the A form of monoamine oxidase by 4-dimethylamino-alpha-methylphenylalkylamine derivatives in the rat.
    Ask AL; Hellström W; Norrman S; Ogren SO; Ross SB
    Neuropharmacology; 1982 Apr; 21(4):299-308. PubMed ID: 7088264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic studies on rat brain monoamine oxidase.
    Huszti Z
    Mol Pharmacol; 1972 Jul; 8(4):385-97. PubMed ID: 5053580
    [No Abstract]   [Full Text] [Related]  

  • 20. Distribution and inhibition characteristics of human brain monoamine oxidase.
    Owen F; Cross AJ; Lofthouse R; Glover V
    Biochem Pharmacol; 1979 Apr; 28(7):1077-80. PubMed ID: 444264
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.